| abstract |
Viral infections are treated by the administration of alpha-interferon at a dosage of from about 0.01 to about 5 IU/lb./day such that the interferon is held in contact with the patient's oral and pharyngeal mucosae. The IFN- alpha is administered in a solid dosage from, e.g., a saliva-dissolvable lozenge. |